“A randomized, single dose, two treatment, two period, crossover bioequivalence study of cefixime (as trihydrate) suspension in healthy participants comparing Acacime® suspension produced by ACAI / Iraq to Suprax® suspension produced by Hikma / Jordan”, AJPS, vol. 17, no. 1, p. 7, Mar. 2018, doi: 10.32947/ajps.v17i1.72.